A molecular switch for neuroprotective astrocyte reactivity
© 2023. The Author(s), under exclusive licence to Springer Nature Limited..
The intrinsic mechanisms that regulate neurotoxic versus neuroprotective astrocyte phenotypes and their effects on central nervous system degeneration and repair remain poorly understood. Here we show that injured white matter astrocytes differentiate into two distinct C3-positive and C3-negative reactive populations, previously simplified as neurotoxic (A1) and neuroprotective (A2)1,2, which can be further subdivided into unique subpopulations defined by proliferation and differential gene expression signatures. We find the balance of neurotoxic versus neuroprotective astrocytes is regulated by discrete pools of compartmented cyclic adenosine monophosphate derived from soluble adenylyl cyclase and show that proliferating neuroprotective astrocytes inhibit microglial activation and downstream neurotoxic astrocyte differentiation to promote retinal ganglion cell survival. Finally, we report a new, therapeutically tractable viral vector to specifically target optic nerve head astrocytes and show that raising nuclear or depleting cytoplasmic cyclic AMP in reactive astrocytes inhibits deleterious microglial or macrophage cell activation and promotes retinal ganglion cell survival after optic nerve injury. Thus, soluble adenylyl cyclase and compartmented, nuclear- and cytoplasmic-localized cyclic adenosine monophosphate in reactive astrocytes act as a molecular switch for neuroprotective astrocyte reactivity that can be targeted to inhibit microglial activation and neurotoxic astrocyte differentiation to therapeutic effect. These data expand on and define new reactive astrocyte subtypes and represent a step towards the development of gliotherapeutics for the treatment of glaucoma and other optic neuropathies.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:626 |
|---|---|
| Enthalten in: |
Nature - 626(2024), 7999 vom: 10. Feb., Seite 574-582 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Cameron, Evan G [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adenylyl Cyclases |
|---|
| Anmerkungen: |
Date Completed 22.02.2024 Date Revised 22.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41586-023-06935-3 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM365771562 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM365771562 | ||
| 003 | DE-627 | ||
| 005 | 20240222232203.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41586-023-06935-3 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1302.xml |
| 035 | |a (DE-627)NLM365771562 | ||
| 035 | |a (NLM)38086421 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Cameron, Evan G |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A molecular switch for neuroprotective astrocyte reactivity |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.02.2024 | ||
| 500 | |a Date Revised 22.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s), under exclusive licence to Springer Nature Limited. | ||
| 520 | |a The intrinsic mechanisms that regulate neurotoxic versus neuroprotective astrocyte phenotypes and their effects on central nervous system degeneration and repair remain poorly understood. Here we show that injured white matter astrocytes differentiate into two distinct C3-positive and C3-negative reactive populations, previously simplified as neurotoxic (A1) and neuroprotective (A2)1,2, which can be further subdivided into unique subpopulations defined by proliferation and differential gene expression signatures. We find the balance of neurotoxic versus neuroprotective astrocytes is regulated by discrete pools of compartmented cyclic adenosine monophosphate derived from soluble adenylyl cyclase and show that proliferating neuroprotective astrocytes inhibit microglial activation and downstream neurotoxic astrocyte differentiation to promote retinal ganglion cell survival. Finally, we report a new, therapeutically tractable viral vector to specifically target optic nerve head astrocytes and show that raising nuclear or depleting cytoplasmic cyclic AMP in reactive astrocytes inhibits deleterious microglial or macrophage cell activation and promotes retinal ganglion cell survival after optic nerve injury. Thus, soluble adenylyl cyclase and compartmented, nuclear- and cytoplasmic-localized cyclic adenosine monophosphate in reactive astrocytes act as a molecular switch for neuroprotective astrocyte reactivity that can be targeted to inhibit microglial activation and neurotoxic astrocyte differentiation to therapeutic effect. These data expand on and define new reactive astrocyte subtypes and represent a step towards the development of gliotherapeutics for the treatment of glaucoma and other optic neuropathies | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Adenylyl Cyclases |2 NLM | |
| 650 | 7 | |a EC 4.6.1.1 |2 NLM | |
| 650 | 7 | |a Cyclic AMP |2 NLM | |
| 650 | 7 | |a E0399OZS9N |2 NLM | |
| 700 | 1 | |a Nahmou, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Toth, Anna B |e verfasserin |4 aut | |
| 700 | 1 | |a Heo, Lyong |e verfasserin |4 aut | |
| 700 | 1 | |a Tanasa, Bogdan |e verfasserin |4 aut | |
| 700 | 1 | |a Dalal, Roopa |e verfasserin |4 aut | |
| 700 | 1 | |a Yan, Wenjun |e verfasserin |4 aut | |
| 700 | 1 | |a Nallagatla, Pratima |e verfasserin |4 aut | |
| 700 | 1 | |a Xia, Xin |e verfasserin |4 aut | |
| 700 | 1 | |a Hay, Sarah |e verfasserin |4 aut | |
| 700 | 1 | |a Knasel, Cara |e verfasserin |4 aut | |
| 700 | 1 | |a Stiles, Travis L |e verfasserin |4 aut | |
| 700 | 1 | |a Douglas, Christopher |e verfasserin |4 aut | |
| 700 | 1 | |a Atkins, Melissa |e verfasserin |4 aut | |
| 700 | 1 | |a Sun, Catalina |e verfasserin |4 aut | |
| 700 | 1 | |a Ashouri, Masoumeh |e verfasserin |4 aut | |
| 700 | 1 | |a Bian, Minjuan |e verfasserin |4 aut | |
| 700 | 1 | |a Chang, Kun-Che |e verfasserin |4 aut | |
| 700 | 1 | |a Russano, Kristina |e verfasserin |4 aut | |
| 700 | 1 | |a Shah, Sahil |e verfasserin |4 aut | |
| 700 | 1 | |a Woodworth, Mollie B |e verfasserin |4 aut | |
| 700 | 1 | |a Galvao, Joana |e verfasserin |4 aut | |
| 700 | 1 | |a Nair, Ramesh V |e verfasserin |4 aut | |
| 700 | 1 | |a Kapiloff, Michael S |e verfasserin |4 aut | |
| 700 | 1 | |a Goldberg, Jeffrey L |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nature |d 1945 |g 626(2024), 7999 vom: 10. Feb., Seite 574-582 |w (DE-627)NLM000008257 |x 1476-4687 |7 nnns |
| 773 | 1 | 8 | |g volume:626 |g year:2024 |g number:7999 |g day:10 |g month:02 |g pages:574-582 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41586-023-06935-3 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 626 |j 2024 |e 7999 |b 10 |c 02 |h 574-582 | ||